In myeloproliferative neoplasms, a link between NRAS mutations and neutrophil hyperleukocytosis via activation of the granulocyte colony-stimulating factor (G-CSF) has been elucidated [115]. The gene discussed is CSF3; the disease is myeloproliferative neoplasm.